메뉴 건너뛰기
Lancet Oncology
Volumn 6, Issue 6, 2005, Pages 353-354
Radioisotopes for metastatic bone pain
Author keywords

[No Author keywords available]
Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PACLITAXEL; RADIOISOTOPE;
EID: 19944365257     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70179-0     Document Type: Letter
Times cited : (2)
References (9)
  • 1
    • 19944386284 scopus 로고    scopus 로고
    • A systematic review of radioisotopes for the palliation of metastatic bone cancer
    • IG Finlay MD Mason M Shelley A systematic review of radioisotopes for the palliation of metastatic bone cancer Lancet Oncol 6 2005 392-400
    • (2005) Lancet Oncol. , vol.6 , pp. 392-400
    • Finlay, I.G.1    Mason, M.D.2    Shelley, M.3
  • 2
    • 0042912982 scopus 로고    scopus 로고
    • Radiotherapy for painful bone metastases: An overview of the overviews
    • DR Roos RJ Fisher Radiotherapy for painful bone metastases: An overview of the overviews Clin Oncol 15 2003 342-344
    • (2003) Clin. Oncol. , vol.15 , pp. 342-344
    • Roos, D.R.1    Fisher, R.J.2
  • 3
    • 0027252452 scopus 로고
    • Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
    • AT Porter AJ McEwan JE Powe et al. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer Int J Radiat Oncol Biol Phys 25 1993 805-813
    • (1993) Int. J. Radiat. Oncol. Biol. Phys. , vol.25 , pp. 805-813
    • Porter, A.T.1    McEwan, A.J.2    Powe, J.E.3
  • 4
    • 0026832260 scopus 로고
    • Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?
    • DP Dearnaley RJ Bayly RP A'Hern et al. Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89? Clin Oncol 4 1992 101-107
    • (1992) Clin. Oncol. , vol.4 , pp. 101-107
    • Dearnaley, D.P.1    Bayly, R.J.2    A'Hern, R.P.3
  • 5
    • 1542713526 scopus 로고    scopus 로고
    • Should all breast cancer patients with symptomatic bone metastases be treated with bisphosphonates? The case against
    • PJ Hoskin Should all breast cancer patients with symptomatic bone metastases be treated with bisphosphonates? The case against Clin Oncol 16 2004 112-114
    • (2004) Clin. Oncol. , vol.16 , pp. 112-114
    • Hoskin, P.J.1
  • 6
    • 1542608527 scopus 로고    scopus 로고
    • Should all breast cancer patients with symptomatic bone metastases be treated with bisphosphonates? The case in support
    • M Clemons Should all breast cancer patients with symptomatic bone metastases be treated with bisphosphonates? The case in support Clin Oncol 16 2004 108-111
    • (2004) Clin. Oncol. , vol.16 , pp. 108-111
    • Clemons, M.1
  • 7
    • 4544287873 scopus 로고    scopus 로고
    • The RIB Trial
    • PJ Hoskin The RIB Trial Clin Oncol 16 2004 445-446
    • (2004) Clin. Oncol. , vol.16 , pp. 445-446
    • Hoskin, P.J.1
  • 8
    • 4744366279 scopus 로고    scopus 로고
    • Docetaxel plus prednisolone or mitoxantrone plus prednisolone for advanced prostate cancer
    • IF Tannock R deWit WR Berry et al. Docetaxel plus prednisolone or mitoxantrone plus prednisolone for advanced prostate cancer N Engl J Med 351 2004 1502-1512
    • (2004) N. Engl. J. Med. , vol.351 , pp. 1502-1512
    • Tannock, I.F.1    deWit, R.2    Berry, W.R.3
  • 9
    • 18444395234 scopus 로고    scopus 로고
    • High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: A phase I study in progressive hormone refractory prostate cancer metastatic to bone
    • JM O'Sullivan VR McCready G Flux et al. High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: A phase I study in progressive hormone refractory prostate cancer metastatic to bone Br J Cancer 86 2002 1715-1720
    • (2002) Br. J. Cancer , vol.86 , pp. 1715-1720
    • O'Sullivan, J.M.1    McCready, V.R.2    Flux, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.